Site specialization

Acquired from Novartis in 2022, the Butantã site (São Paulo) has been key to Unither’s industrial development in Brazil. It strengthens the Group’s presence in Latin America with aseptic capacities for ophthalmic multi-dose forms with preservatives.

Key figures

180

employees

60 million

vials/year

Expertise and know-how

Analytical Development

The entire development and production cycle: from formulation to manufacturing and regulatory support.

Development

Formulation and analytical development, manufacture of clinical batches, stability studies, and expertise in ophthalmic development.

Regulatory Support

Comprehensive regulatory support, from pharmaceutical development to CTD/eCTD document submission.

Locally manufactured products

Multi-dose vials with preservatives
Ophthalmic and respiratory products

Multi-doses with preservatives

1.5 – 15 mL

Standards and certifications

Authorizations:

– ANVISA (Brazil),
– INVIMA (Colombia),
– DIGEMID (Peru)
– DRAP (Pakistan).
Standards and certifications:
– Good Manufacturing Practices (GMP – ANVISA)
– ICH and WHO compliance for stability studies
– Certified aseptic processes

Address

Address:
Unither Butantã
Avenida Nossa Senhora da Assunção, 736
Butantã – São Paulo SP 05359-902
Brazil

 

Contact:
Phone: +55 (11) 3732-4450
Email: contact@unither-pharma.com

 

How to get here:
By road: 15 km from the center of São Paulo, via Marginal Pinheiros
By plane: Congonhas (20 km) or Guarulhos (45 km) airports
By train: Luz Station (approx. 22 km)